(Q35790834)

10 August 2017

1 reference

title

Role of interferons in the treatment of severe acute respiratory syndrome (English)

1 reference

10 August 2017

4

Hans Wilhelm Doerr

1 reference

10 August 2017

1

Jindrich Cinatl

1 reference

10 August 2017

2

Martin Michaelis

1 reference

10 August 2017

Martin Scholz

3

1 reference

PubMed ID

15174965

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Expert Opinion on Biological Therapy

10 August 2017

1 reference

10 August 2017

4

1 reference

10 August 2017

827-836

1 reference

10 August 2017

6

1 reference

SARS--beginning to understand a new virus

10 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

The severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Potential for antiviral treatment of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

A major outbreak of severe acute respiratory syndrome in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Identification of severe acute respiratory syndrome in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Interferon-beta 1a and SARS coronavirus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

21 January 2018

Viruses and interferons

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Viruses and interferon: a fight for supremacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Regulation of JAK-STAT signalling in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Signaling through the JAK/STAT pathway, recent advances and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Whence interferon? Variety in the production of interferon in response to viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Antiviral actions of interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

PACT, a protein activator of the interferon-induced protein kinase, PKR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Influenza virus resistance of wild mice: wild-type and mutant Mx alleles occur at comparable frequencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Mechanism of interferon action: double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

The dsRNA binding protein family: critical roles, diverse cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Serotonin-2C receptor pre-mRNA editing in rat brain and in vitro by splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Comparative susceptibility of respiratory viruses to recombinant interferons-alpha 2b and -beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Chicken interferon type I inhibits infectious bronchitis virus replication and associated respiratory illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Protective effect of recombinant murine interferon beta against mouse hepatitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Acquired immunity of A/J mice to mouse hepatitis virus 3 infection: dependence on interferon- synthesis and macrophage sensitivity to interferon-

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Interferon gamma potentiates human coronavirus OC43 infection of neuronal cells by modulation of HLA class I expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Synergistic antiviral effect of a combination of mouse interferon-alpha and interferon-gamma on mouse hepatitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Aminoglycoside-phosphotransferases APH(3')-IV and APH(3") synthesized by a strain of Campylobacter coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

SARS treatment. Interferon shows promise in monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Expression of human and macaque type I IFN transgenes interferes with HSV-1 replication at the transcriptional and translational levels: IFN-beta is more potent than IFN-alpha 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

A comparison of the biologic activity of two recombinant IFN-beta preparations used in the treatment of relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

A clinicopathological study of three cases of severe acute respiratory syndrome (SARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

How the SARS vaccine effort can learn from HIV?speeding towards the future, learning from the past

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Chemokine regulation of inflammation during acute viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.827

Characterization of transgenic mice with targeted disruption of the catalytic domain of the double-stranded RNA-dependent protein kinase, PKR.

21 January 2018

1 reference

12 December 2020

Functional classification of interferon-stimulated genes identified using microarrays

1 reference

12 December 2020

Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures

1 reference

12 December 2020

A cluster of cases of severe acute respiratory syndrome in Hong Kong.

1 reference

12 December 2020

Coronavirus pseudoparticles formed with recombinant M and E proteins induce alpha interferon synthesis by leukocytes.

1 reference

12 December 2020

Treatment of SARS with human interferons.

1 reference

12 December 2020

Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

1 reference

12 December 2020

Improved pharmacokinetic properties of a polyethylene glycol-modified form of interferon-beta-1a with preserved in vitro bioactivity.

1 reference

12 December 2020

Pegylated interferon plus ribavirin for the treatment of chronic hepatitis C.

1 reference

12 December 2020

Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis

1 reference

12 December 2020

Treatment of SARS with human interferons

1 reference

12 December 2020

Comparison of the replication of distinct strains of human coronavirus OC43 in organotypic human colon cells (Caco-2) and mouse intestine.

1 reference

12 December 2020

Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.

1 reference

12 December 2020

Prevention of experimental coronavirus colds with intranasal alpha-2b interferon

1 reference

12 December 2020

Antiviral activity against transmissible gastroenteritis virus, and cytotoxicity, of natural porcine interferons alpha and beta

1 reference

12 December 2020

Current and future treatment of hepatitis C.

1 reference

12 December 2020

Old drugs for a new bug: influenza, HIV drugs enlisted to fight SARS.

1 reference

12 December 2020

Lowered yields of virus-induced interferon production in leukocyte cultures and risk of recurrent respiratory infections in children

1 reference

12 December 2020

Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs

1 reference

12 December 2020

Interferon alfacon-1: a review of its pharmacology and therapeutic efficacy in the treatment of chronic hepatitis C.

1 reference

12 December 2020

The efficacy and tolerance of intranasal interferons: studies at the Common Cold Unit

1 reference

12 December 2020

Interferon-induced proteins and the antiviral state.

1 reference

12 December 2020

Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA.

1 reference

12 December 2020

Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha

1 reference

12 December 2020

A monomeric GTPase-negative MxA mutant with antiviral activity

1 reference

12 December 2020

Development of a standard treatment protocol for severe acute respiratory syndrome

1 reference

12 December 2020

Systemic IFN-beta treatment induces apoptosis of peripheral immune cells in MS patients.

1 reference

12 December 2020

Is flavivirus resistance interferon type I-independent?

1 reference

12 December 2020

Identifiers

DOI

10.1517/14712598.4.6.827

1 reference

10 August 2017

0 references

1 reference

PubMed ID

15174965